A vibrant US healthcare sector is generating good momentum for Cello Health PLC (LON:CLL), says chief executive Mark Scott. R&D spending and innovation are high, which is driving business towards its healthcare communications and consulting arms.
Existing accounts are growing while the addition of new customers is strong, he told Proactive.
Cello is also generating plenty of cash, he adds and unless it makes another sizeable purchase should finish the year with a healthy balance.
Scott wants to add to the company’s footprint in the US, though he says prices in the US reflect just how strong the market there is at present.
0 Comments